|HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa|
JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ...
PLoS medicine 9 (7), e1001245, 2012
|Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …|
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
|Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic …|
M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ...
The Lancet Public Health 1 (1), e8-e17, 2016
|Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial|
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
|The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa|
JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ...
AIDS (London, England) 26 (0 1), 2012
|Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study|
JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ...
PLoS medicine 10 (10), e1001534, 2013
|Ageing with HIV in south africa|
JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ...
AIDS (London, England) 25 (13), 2011
|HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making|
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
|Costs, effects and cost‐effectiveness of breast cancer control in Ghana|
SG Zelle, KM Nyarko, WK Bosu, M Aikins, LM Niëns, JA Lauer, ...
Tropical Medicine & International Health 17 (8), 1031-1043, 2012
|Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness|
R Baltussen, MP Jansen, E Mikkelsen, N Tromp, J Hontelez, L Bijlmakers, ...
International journal of health policy and management 5 (11), 615, 2016
|Time and money: the true costs of health care utilization for patients receiving ‘free’HIV/TB care and treatment in rural KwaZulu-Natal|
N Chimbindi, J Bor, ML Newell, F Tanser, R Baltusen, J Hontelez, ...
Journal of acquired immune deficiency syndromes (1999) 70 (2), e52, 2015
|The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa|
JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ...
PloS one 6 (7), e21919, 2011
|Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral …|
JW Eaton, N Bacaër, A Bershteyn, V Cambiano, A Cori, RE Dorrington, ...
The Lancet Global Health 3 (10), e598-e608, 2015
|Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained?|
SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ...
PLoS neglected tropical diseases 10 (2), e0004386, 2016
|Balancing efficiency, equity and feasibility of HIV treatment in South Africa–development of programmatic guidance|
R Baltussen, E Mikkelsen, N Tromp, AK Hurtig, J Byskov, Ø Olsen, ...
Cost Effectiveness and Resource Allocation 11 (1), 1-9, 2013
|Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study|
R Atun, AY Chang, O Ogbuoji, S Silva, S Resch, J Hontelez, ...
BMJ open 6 (3), e009656, 2016
|Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia?|
R Steen, JAC Hontelez, A Veraart, RG White, SJ de Vlas
Aids 28 (6), 891-899, 2014
|Evidence for scaling up HIV treatment in sub-Saharan Africa: a call for incorporating health system constraints|
E Mikkelsen, JAC Hontelez, MPM Jansen, T Bärnighausen, K Hauck, ...
PLoS medicine 14 (2), e1002240, 2017
|The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model|
JAC Hontelez, N Nagelkerke, T Bärnighausen, R Bakker, F Tanser, ...
Vaccine 29 (36), 6100-6106, 2011
|Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness|
JAC Hontelez, AY Chang, O Ogbuoji, SJ de Vlas, T Bärnighausen, R Atun
AIDS (London, England) 30 (15), 2341, 2016